The SLE is caused by immune complexes depositing on organs and extensive injury were caused.7 The patients with SLE are characterized by BCR-initiated signaling and IL-6 production, including alter in B cell subset distribution.8 Therefore, the main clinical strategy for treating SLE was blocking the immune cells stimulating cytokine that affects the development of SLE. Here, BCR is linked to systemic lupus erythematosus.